Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
J-TASTE: Azilsartan vs candesartan in HFpEF with hypertension
jRCTs051180137Completed
- Sponsor
- Takeda
- Start
- Aug 2016
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised trial in heart failure with preserved ejection fraction (HFpEF), left ventricular diastolic dysfunction (LVDD) and hypertension (HTN) comparing Azilsartan arm with Candesartan arm (2 arms). Primary endpoint: Change in E/e'. Started Aug 2016; status: completed.
02
Drugs
azilsartancandesartan
03
Conditions
heart failure with preserved ejection fraction (HFpEF)left ventricular diastolic dysfunction (LVDD)hypertension (HTN)
Beyond the preview
Go deeper on jRCTs051180137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180137.